← Back to Search

Mobile App for Depression in Multiple Sclerosis (MS-CATCH Trial)

N/A

Recruiting

Led By Riley Bove, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-12 months, 0-6 months, 6-12 months

Awards & highlights

MS-CATCH Trial Summary

This trial aims to see if MS CATCH can improve the patient-doctor relationship and increase patient satisfaction.

Who is the study for?

This trial is for California residents aged 18-80 with Multiple Sclerosis, who can use a mobile app and have mild to moderate depression. They must be able to give consent and follow the study plan without being limited by cognitive or visual issues, and should not have bipolar disorder, schizophrenia, or schizoaffective disorder.Check my eligibility

What is being tested?

The MS CATCH smartphone application is being tested to see if it improves patient care in those with Multiple Sclerosis and depression. It lets patients report mood symptoms regularly for their neurologist to monitor through their medical records.See study design

What are the potential side effects?

Since this trial involves using a mobile application rather than medication, traditional side effects are not expected. However, participants may experience stress or discomfort from regular self-monitoring of depressive symptoms.

MS-CATCH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-12 months, 0-6 months, 6-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-12 months, 0-6 months, 6-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-12 months, 0-6 months, 6-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adoption (uptake) - Primary

Adoption (uptake) - Secondary

Comprehensive Mood Evaluation - Secondary

+4 more

Secondary outcome measures

Adherence - Secondary

Engagement (Sustained use) - Exploratory

Engagement (Sustained use) - Exploratoy

+8 more

Other outcome measures

Self-Efficacy - Exploratory

Trial retention - Exploratory

MS-CATCH Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm 2: 6 month "usual care", 6 month MS CATCH tool interventionExperimental Treatment1 Intervention

Participants in arm 2 will receive 6 months "usual care" followed by 6 months of MS CATCH tool intervention. These first 6 months will be used to assess the definition of "usual care".

Group II: Arm 1: 12 month MS CATCH tool interventionExperimental Treatment1 Intervention

Participants in arm 1 will receive 12 months of use of the MS CATCH tool. This will include in-visit interventions and monthly questionnaires.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,238,475 Total Patients Enrolled

23 Trials studying Multiple Sclerosis

2,430 Patients Enrolled for Multiple Sclerosis

United States Department of DefenseFED

865 Previous Clinical Trials

327,599 Total Patients Enrolled

11 Trials studying Multiple Sclerosis

734 Patients Enrolled for Multiple Sclerosis

Riley Bove, MDPrincipal InvestigatorUniversity of California, San Francisco

6 Previous Clinical Trials

394 Total Patients Enrolled

6 Trials studying Multiple Sclerosis

394 Patients Enrolled for Multiple Sclerosis

Media Library

Arm 1: 12 month MS CATCH tool intervention Clinical Trial Eligibility Overview. Trial Name: NCT05865405 — N/A

Multiple Sclerosis Research Study Groups: Arm 1: 12 month MS CATCH tool intervention, Arm 2: 6 month "usual care", 6 month MS CATCH tool intervention

Multiple Sclerosis Clinical Trial 2023: Arm 1: 12 month MS CATCH tool intervention Highlights & Side Effects. Trial Name: NCT05865405 — N/A

Arm 1: 12 month MS CATCH tool intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05865405 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must an individual meet to participate in this research?

"This clinical trial is seeking 100 people who are between 18 and 80 years old, with an existing diagnosis of multiple sclerosis."

Answered by AI

Are there any available vacancies to participate in this research project?

"Clinicialtrials.gov displays that this medical research is not currently enrolling participants. Having been posted on May 15th of 2023 and last updated on the 9th, it has concluded its recruitment phase; however, there are over one thousand nine hundred other trials actively recruiting at present."

Answered by AI

Is eligibility for this research restricted to any particular age group?

"This research trial can only be joined by those aged between 18 and 80 years old. However, there are 250 studies available for minors below the age of consent and 1398 particular to individuals 65 or older."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis

2023. "A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05865405.